tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Venus Remedies Aligns with SEBI’s Investment Ease Initiative

Story Highlights
Venus Remedies Aligns with SEBI’s Investment Ease Initiative

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Venus Remedies Limited ( (IN:VENUSREM) ) has provided an update.

Venus Remedies Limited has announced the re-lodgement of shares for transfer cum dematerialization in compliance with a SEBI circular, covering the period from July 7 to July 31, 2025. This move is part of a broader regulatory effort to streamline investment processes, potentially impacting the company’s operational efficiency and investor relations by aligning with SEBI’s ease of doing investment initiatives.

More about Venus Remedies Limited

Venus Remedies Limited operates in the pharmaceutical industry, focusing on the production and distribution of a wide range of medicinal products. The company is known for its emphasis on research and development to deliver innovative healthcare solutions.

Average Trading Volume: 6,001

Technical Sentiment Signal: Buy

Current Market Cap: 6.61B INR

For an in-depth examination of VENUSREM stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1